Aspirin Thromboprophylaxis in Joint Replacement Surgery

Joint replacement surgery.

Joint replacement is the most effective healthcare measure in improving patient quality-of-life outcomes. More than 46000 hip and knee replacements were performed in Australia between July 2000 and July 2001. The need for joint replacements will increase as the population ages. More than 90% of hip and/or knee replacements survive for 10-15 years. Prosthesis selection needs to be tailored to ea...

Computer-navigated joint-replacement surgery

Aspirin: benefit and risk in thromboprophylaxis.

Aspirin is often perceived either as a harmless panacea or as a useless poison which causes endless, needless trouble. We have carefully reviewed the literature on all aspects of aspirin and find that neither view is justified. Regular use of even low-dose aspirin (150 mg/day or less) may lead to clinically-important adverse events, particularly haemorrhage. The risk of such an event is conside...

Survival analysis in joint replacement surgery.

After the widespread introduction of joint replacement surgery the early reports of outcome described success in terms of relief of pain, restoration of movement and the ability to return to normal activities. These were subsequently refined to include some assessment of the longevity of the implant and many reports now describe excellent success rates over long periods of time. The pioneering ...

Joint Replacement Surgery in Parkinson's Disease